Critical roles for interleukin-4 and interleukin-5 during respiratory syncytial virus infection in the development sf airway hyperresponsiveness after airway sensitization
J. Schwarze et al., Critical roles for interleukin-4 and interleukin-5 during respiratory syncytial virus infection in the development sf airway hyperresponsiveness after airway sensitization, AM J R CRIT, 162(2), 2000, pp. 380-386
In mice, respiratory syncytial virus (RSV) infection can enhance the conseq
uences of allergic airway sensitization, resulting in lung eosinophilia and
the development of airway hyperresponsiveness (AHR) to inhaled methacholin
e (MCh). To delineate a role for interleukin-5 (IL-5), interleukin-4 (IL-4)
, and interferon gamma (IFN-gamma) in mediating the effects of RSV infectio
n on subsequent allergic sensitization, we treated BALB/c mice with anti-IL
-5 during acute RSV infection but not during subsequent exposure to ovalbum
in (OVA). IL-5-deficient and IL-deficient mice were also treated with IL-5
either during acute RSV infection or during the sensitization period. Airwa
y responsiveness to inhaled MCh was assessed and numbers of lung eosinophil
s were monitored. Anti-IL-5 treatment during RSV infection reduced AHR and
lung eosinophilia after subsequent exposure to allergen. In IL-5-deficient
or IL-4-deficient mice lung eosinophilia and AHR after RSV infection and al
lergen exposure were also markedly reduced. IL-5 administration during RSV
infection restored the responses to allergen in both IL-5- and IL-4-deficie
nt mice. However, IL-5 administration only during sensitization restored th
ese responses in IL-4-deficient but not in IL-5-deficient animals. IFN-gamm
a-deficient mice developed AHR and some lung eosinophilia after allergen ex
posure alone and when RSV infection preceded allergen, these responses were
enhanced. We conclude that both IL-5, particularly during acute infection,
and IL-4 are critical in mediating the effects of RSV infection on allergi
c airway sensitization, resulting in the development of AHR and lung eosino
philia.